Wallenberg syndrome in a patient after pulmonary resection: a case report

Tsubasa Matsuo1, Daisuke Kimura2, Kengo Tani2

  • 1Department of Thoracic and Cardiovascular Surgery, Graduate School of Medicine, Hirosaki University, Hirosaki City, Aomori, Japan. tsubasa1986side@gmail.com.

Abstract

Insights

A rare case of Wallenberg syndrome, a type of cerebral infarction, occurred after lung surgery. Prompt diagnosis and anticoagulation therapy were crucial for patient recovery following the vertebral artery occlusion.

Area of Science:

  • Neurology
  • Cardiology
  • Thoracic Surgery

Background:

  • Cerebral infarction is a rare but serious complication following pulmonary resection.
  • Postoperative Wallenberg syndrome, caused by posterior inferior cerebral artery infarction, is an exceptionally uncommon occurrence after lobectomy.

Purpose of the Study:

  • To report a rare case of Wallenberg syndrome following left upper lobectomy.
  • To highlight the diagnostic challenges and management of posterior circulation cerebral infarction in the postoperative setting.

Main Methods:

  • A 72-year-old male patient underwent left upper lobectomy for lung cancer.
  • Postoperatively, the patient presented with symptoms suggestive of cerebral infarction.
  • Magnetic resonance imaging (MRI) revealed right vertebral artery occlusion, and contrast-enhanced computed tomography (CT) excluded pulmonary vein thrombus.

Main Results:

  • The patient was diagnosed with Wallenberg syndrome, characterized by infarction in the lateral medulla and cerebellum.
  • Prompt anticoagulation therapy was initiated upon diagnosis.
  • The patient was discharged on postoperative day 16 for rehabilitation.

Conclusions:

  • This case highlights the possibility of Wallenberg syndrome due to vertebral artery occlusion after lobectomy.
  • Differentiating posterior circulation cerebral infarction from anesthetic side effects requires meticulous physical examination.
  • Early recognition and management are vital for favorable outcomes in such rare postoperative neurological complications.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...